Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079121 | SCV000110990 | benign | not specified | 2013-05-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079121 | SCV000304769 | benign | not specified | 2017-08-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079121 | SCV000532764 | likely benign | not specified | 2018-03-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002055105 | SCV002347745 | benign | RYR1-related disorder | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490684 | SCV002803641 | benign | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004703208 | SCV005207188 | likely benign | not provided | criteria provided, single submitter | not provided |